Protection by taurine and thiotaurine against biochemical and cellular alterations induced by diabetes in a rat model

Advances in Experimental Medicine and Biology

Volumn 775, Issue , 2013, Pages 321-343

  Budhram, Roshil ^a   Pandya, Kashyap G ^a   Lau Cam, Cesar A ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CHOLESTEROL; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN A1C; ISOPHANE INSULIN; MALONALDEHYDE; SPECTRIN; SUPEROXIDE DISMUTASE; TAURINE; TAURINE DERIVATIVE; THIOTAURINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ANTIOXIDANT; DRUG DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; INSULIN; PHOSPHOLIPID; PROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL LEVEL; CHOLESTEROL BLOOD LEVEL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE CONTROL; DRUG BLOOD LEVEL; DRUG EFFICACY; ERYTHROCYTE MEMBRANE; ERYTHROCYTE STRUCTURE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPOINSULINEMIA; INSULIN BLOOD LEVEL; MALE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RAT; RAT MODEL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CELL SHAPE; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; ERYTHROCYTE; EXPERIMENTAL DIABETES MELLITUS; LIPID PEROXIDATION; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CATALASE; CELL SHAPE; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ERYTHROCYTES; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN A, GLYCOSYLATED; INSULIN; LIPID PEROXIDATION; MALE; PHOSPHOLIPIDS; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SPECTRIN; SUPEROXIDE DISMUTASE; TAURINE; TRIGLYCERIDES;

MLCS; MLOWN;

EID: 84875619663     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-6130-2_27     Document Type: Article

References (62)

1. Acharya M, Lau-Cam CA (2010) Comparison of the protective actions of N -acetylcysteine, hypotaurine and taurine against acetaminophen-induced hepatotoxicity in the rat. J Biomed Sci 17:S35
2. Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121-126
3. Alciguzel Y, Ozen I, Aslan M, Karayalcin U (2003) Activities of xanthine oxidoreductase and antioxidant enzymes in different tissues of diabetic rats. J Lab Clin Med 142:172-177
4. Arora S, Ojha SK, Vohora D (2009) Characterisation of streptozotocin induced diabetes mellitus in Swiss albino mice. Global J Pharmacol 3:81-84
5. Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1-9
6. Beard KM, Shangari N, Wu B, O'Brien PJ (2003) Metabolism, not autoxidation, plays a role in a -oxoaldehyde- and reducing sugar-induced erythrocyte GSH depletion: relevance for diabetes mellitus. Mol Cell Biochem 252:331-338
7. Brøns C, Spohr C, Storgaard H, Dyerberg J, Vaag A (2004) Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus. Eur J Clin Nutr 58:1239-1247
8. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820
9. Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625
10. Ceriello A (2005) Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 54:1-7
11. Chauncey KB, Tenner TE Jr, Lombardini JB et al (2003) The effect of taurine supplementation on patients with type 2 diabetes mellitus. Adv Exp Med Biol 526:91-96
12. Cherif H, Reusens B, Ahn MT, Hoet JJ, Remacle C (1998) Effects of taurine on the insulin secretion of rat fetal islets from dams fed a low-protein diet. J Endocrinol 159:341-348
13. Costagliola C (1990) Oxidative state of glutathione in red blood cells and plasma of diabetic patients: in vivo and in vitro study. Clin Physiol Biochem 8:204-210
14. Darmaun D, Smith SD, Sweeten S, Sager BK, Welch S, Mauras N (2005) Evidence for accelerated rates of glutathione utilization and glutathione depletion in adolescents with poorly controlled type 1 diabetes. Diabetes 54:190-196
15. Desco MC, Asensi N, Márquez R et al (2002) Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes 51:1118-1124
16. Desouky OS (2009) Rheological and electrical behavior of erythrocytes in patients with diabetes mellitus. Rom J Biophys 19:239-250
17. Folch J, Lees M, Stanley GHS (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497-509
18. Fujiwara Y, Kondo T, Murakami K, Kawakami Y (1989) Decrease of the inhibition of lipid peroxidation by glutathione-dependent system in erythrocytes of non-insulin dependent diabetics. J Mol Med 67:336-341
19. Goodman HO, Shihabi ZK (1990) Supplemental taurine in diabetic rats: effects on plasma glucose and triglycerides. Biochem Med Metab Biol 43:1-9
20. Gossai D, Lau-Cam CA (2009) The effects of taurine, taurine homologs and hypotaurine on cell and membrane antioxidative system alterations caused by type 2 diabetes in rat erythrocytes. Adv Exp Med Biol 643:359-368
21. Gunzler WA, Flohé L (1985) Glutathione peroxidase. In: Greenwald RA (ed) CRC handbook of methods for oxygen radical research. CRC, Boca Raton, FL, pp 285-290
22. Guzik TJ, Mussa S, Gastaldi D et al (2002) Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105:1656-1662
23. Hisalkar PJ, Patne AB, Fawade MM (2012) Assessment of plasma antioxidant levels in type 2 diabetes patients. Int J Biol Med Res 3:1796-1800
24. Hissin PJ, Hilf R (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74:214-226
25. Jain SK (1984) The accumulation of malonyldialdehyde, a product of fatty acid peroxidation, can disturb aminophospholipid organization in the membrane bilayer of human erythrocytes. J Biol Chem 259:3391-3394
26. Jain SK, Levine SN, Duetta J, Hollier B (1990) Elevated lipid peroxidation levels in red blood cells of streptozotocin-treated diabetic rats. Metabolism 39:971-975
27. Jain SK, McVie R, Duett J, Herbst JJ (1989) Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 38:1539-1543
28. Jarvi AE, Karlstrom BE, Granfeldt YE et al (1999) Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients. Diabetes Care 22:10-18
29. Kalapos MP, Andrea Littauer A, de Groot H (1993) Has reactive oxygen a role in methylglyoxal toxicity? A study on cultured rat hepatocytes. Arch Toxicol 67:369-372
30. Kedziora-Kornatowska KZ, Luciak M, Blaszczyk J, Pawlak W (1998) Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with non-insulin dependent diabetes with or without diabetic nephropathy. Nephrol Dial Transplant 13:2829-2832
31. Lee AY, Chiung SS (1999) Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J 13:23-30
32. Likidlilid A, Patchanans N, Peerapatdit T, Sriratanasathavorn C (2010) Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients. J Med Assoc Thai 93:682-693
33. Maritim AC, Moore BH, Sanders RA, Watkins JB III (1999) Effects of melatonin on oxidative stress in streptozotocin-induced diabetic rats. Int J Toxicol 18:161-166
34. Maritim AC, Sanders RA, Watkins JB III (2003) Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17:24-38
35. Maturo J, Kulakowski EC (1988) Taurine binding to the purified insulin receptor. Biochem Pharmacol 37:3755-3760
36. Mayfield J (1998) Diagnosis and classification of diabetes mellitus: new criteria. Am Fam Physician 58:1355-1362
37. Misra HP, Fridovich I (1972) The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247:3170-3175
38. Moller DE (2001) New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414(6865):821-827
39. Monnier L, Mas E, Ginet C et al (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. J Am Med Assoc 295:1681-1687
40. Murakami K, Takahito K, Ohtsuka Y et al (1989) Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabolism 38:753-758
41. Nandhini ATA, Thirunavukkarasu V, Anuradha CV (2004) Stimulation of glucose utilization and inhibition of protein glycation and AGE products by taurine. Acta Physiol Scand 181:297-303
42. Nishikawa T, Edelstein D, Brownlee M (2000) The missing link: a single unifying mechanism for diabetic complications. Kidney Int 58:S26-S30
43. Obrosova IG, Stavniichuk R, Drel VR (2010) Different roles of 12/15-lipoxygenase in diabetic large and small fiber peripheral and autonomic neuropathies. Am J Pathol 177:1436-1447
44. Oprescu AI, Bikopoulos G, Naassan A et al (2007) Fatty acid-induced reduction in glucose-stimulated insulin secretion: evidence for a role of oxidative stress in vitro and in vivo. Diabetes 56:2927-2937
45. Peuchant E, Delmas-Beauvieux MC, Couchouron A et al (1997) Short-term insulin therapy and normoglycemia. Effects on erythrocyte lipid peroxidation in NIDDM patients. Diabetes Care 20:202-207
46. Pieczenik SR, Neustadt J (2007) Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol 83:84-92
47. Rahimi R, Nikfar S, Larijani B, Abdollahi M (2005) A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 59:365-373
48. Ricci C, Pastukh V, Leonard J et al (2008) Mitochondrial DNA damage triggers mitochondrial superoxide generation and apoptosis. Am J Physiol Cell Physiol 294:C413-C422
49. Schaffer SW, Azuma J, Mozaffari M (2009) Role of antioxidant activity of taurine in diabetes. Can J Physiol Pharmacol 87:91-99
50. Sekhar RV, McKay SV, Patel SG et al (2010) Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care 34:164-167
51. Sharma R, Premachandra BR (1991) Membrane-bound hemoglobin as a marker of oxidative injury in adult and neonatal red blood cells. Biochem Med Metab Biol 46:33-44
52. Stewart JCM (1979) Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 104:10-14
53. Straface E, Rivabene R, Masella R et al (2002) Structural changes of the erythrocyte as a marker of non-insulin-dependent diabetes: protective effects of N-acetylcysteine. Biochem Biophys Res Commun 290:1393-1398
54. Sundaram RK, Bhaskar A, Vijayalingam S et al (1996) Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci 90:255-260
55. Tenner TE Jr, Zhang XJ, Lombardini JB (2003) Hypoglycemic effects of taurine in the alloxantreated rabbit: a model for type 1 diabetes. Adv Exp Med Biol 526:97-104
56. Tokunaga H, Yoneda Y, Kuriyama K (1979) Protective actions of taurine against streptozotocininduced hyperglycemia. Biochem Pharmacol 28:2807-2811
57. Tourrel C, Bailbe D, Lacorne M, Meile MJ, Kergoat M, Portha B (2002) Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the b -cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4. Diabetes 51:1443-1452
58. Trachtman H, Futterweit S, Maesaka J, Ma C, Valderrama E, Fuchs A, Tarectecan AA, Rao PS, Sturman JA, Boles TH (1995) Taurine ameliorates chronic streptozotocin-induced diabetic nephropathy in rats. Am J Physiol 269:F429-F438
59. Trocino RA, Akazawa S, Ishibashi M et al (1995) Significance of glutathione depletion and oxidative stress in early embryogenesis in glucose-induced rat embryo culture. Diabetes 44: 992-998
60. Winiarska K, Szymanski K, Gorniak P, Dudziak M, Bryla J (2009) Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits. Biochimie 91:261-270
61. Wohaieb SA, Godin DV (1987) Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rat. Effects of insulin treatment. Diabetes 36:1014-1018
62. Ziparo E, Lemay A, Marchesi VT (1978) The distribution of spectrin along the membranes of normal and echinocytic human erythrocytes. J Cell Sci 34:91-101